Vytorin: Difference between revisions

Line 26:

===<b>Simvastatin</b>===

When the drug is administered it is initially inactive. It must be hydrolyzed in order to become active. Once hydrolyzed, simvastatin reduces the amount of mevalonic acid in the blood by competing for HMG-CoA reductase with HMG-CoA. To produce cholesterol, Acetyl CoA is converted into HMG-CoA, which is then converted into mevalonate. Mevalonate is then converted into isopentenyl pyrophosphate (IPP), IPP is converted into squalene, and then finally squalene is converted into cholesterol. Simvastatin reduces the conversion of HMG-CoA to mevalonate, therefore lowering cholesterol levels. Simvastatin targets <scene name='75/757901/Hmg-coa_reductase_w_simvastin/1'>HMG-CoA reductase</scene> which is the enzyme responsible for said conversion. With the synthesis of cholesterol being divided into 5 major steps, this inability to convert targets only the second step in cholesterol synthesis.

When the drug is administered it is initially inactive. It must be hydrolyzed in order to become active. Once hydrolyzed, simvastatin reduces the amount of mevalonic acid in the blood by competing for HMG-CoA reductase with HMG-CoA. To produce cholesterol, Acetyl CoA is converted into HMG-CoA, which is then converted into mevalonate. Mevalonate is then converted into isopentenyl pyrophosphate (IPP), IPP is converted into squalene, and then finally squalene is converted into cholesterol. Simvastatin reduces the conversion of HMG-CoA to mevalonate, therefore lowering cholesterol levels. Simvastatin targets <scene name='75/757901/Hmg-coa_reductase_w_simvastin/1'>HMG-CoA reductase</scene> which is the enzyme responsible for said conversion. With the synthesis of cholesterol being divided into five major steps, this inability to convert targets only the second step in cholesterol synthesis.<ref>http://www.merck.com/product/usa/pi_circulars/v/vytorin/vytorin_pi.pdf</ref>

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

Revision as of 02:28, 20 April 2017 view source Carley Sadler (talk \| contribs) 34 edits No edit summary ← Older edit		Revision as of 02:31, 20 April 2017 view source Carley Sadler (talk \| contribs) 34 edits No edit summary Newer edit →
Line 26:		Line 26:
	===<b>Simvastatin</b>===		===<b>Simvastatin</b>===

	When the drug is administered it is initially inactive. It must be hydrolyzed in order to become active. Once hydrolyzed, simvastatin reduces the amount of mevalonic acid in the blood by competing for HMG-CoA reductase with HMG-CoA. To produce cholesterol, Acetyl CoA is converted into HMG-CoA, which is then converted into mevalonate. Mevalonate is then converted into isopentenyl pyrophosphate (IPP), IPP is converted into squalene, and then finally squalene is converted into cholesterol. Simvastatin reduces the conversion of HMG-CoA to mevalonate, therefore lowering cholesterol levels. Simvastatin targets <scene name='75/757901/Hmg-coa_reductase_w_simvastin/1'>HMG-CoA reductase</scene> which is the enzyme responsible for said conversion. With the synthesis of cholesterol being divided into 5 major steps, this inability to convert targets only the second step in cholesterol synthesis.		When the drug is administered it is initially inactive. It must be hydrolyzed in order to become active. Once hydrolyzed, simvastatin reduces the amount of mevalonic acid in the blood by competing for HMG-CoA reductase with HMG-CoA. To produce cholesterol, Acetyl CoA is converted into HMG-CoA, which is then converted into mevalonate. Mevalonate is then converted into isopentenyl pyrophosphate (IPP), IPP is converted into squalene, and then finally squalene is converted into cholesterol. Simvastatin reduces the conversion of HMG-CoA to mevalonate, therefore lowering cholesterol levels. Simvastatin targets <scene name='75/757901/Hmg-coa_reductase_w_simvastin/1'>HMG-CoA reductase</scene> which is the enzyme responsible for said conversion. With the synthesis of cholesterol being divided into five major steps, this inability to convert targets only the second step in cholesterol synthesis.<ref>http://www.merck.com/product/usa/pi_circulars/v/vytorin/vytorin_pi.pdf</ref>